Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 691 results found. Search for [ COVID-19 vaccine update ]

Results 40 to 60 of 691
BusinessToday.In
November 20, 2020
The researchers said that COVID-19 infection rates between March and August across 15 countries, including UK, France, Italy, and Belgium were on an average 6.2 times higher than the reported cases


BusinessToday.In
November 20, 2020
India Stock Highlights Updates Today: Bajaj Finserv followed by Tata Steel, Titan, Bajaj Finance, HDFC twins and Kotak Bank were among the top gainers on Sensex pack. On the other hand, ICICI Bank, ONGC, Axis Bank, SBI and IndusInd Bank were among the laggards


BusinessToday.In
November 20, 2020
Adar Poonawalla said if things go according to the plan, the coronavirus vaccine will be available for vulnerable populations by January or February. And, in March or April, the vaccine will enter the market for the general public


Rajeev Dubey
November 20, 2020
Emboldened, firms indulge in a game of one-upmanship based on alarmingly low number of trials. Sputnik had been tried on only 20 patients before Gamaleya made the claim; Pfizer 120 and Moderna 95


BusinessToday.In
November 19, 2020
Late-stage trials of the Oxford vaccine are still awaited but hopes are high that it'll also join frontrunners' league with Pfizer, Moderna and Russia's Sputnik V


BusinessToday.In
New Delhi, November 19, 2020
US pharma giants Pfizer and Moderna have released the results of clinical trials of their respective experimental coronavirus vaccines, with both reporting an efficacy of over 90 per cent. The Russian vaccine, Sputnik V has also shown encouraging results in the late-stage trials. By when will the first coronavirus vaccine be ready? Watch as the experts explain the status of the global COVID-19 vaccines, with their existing challenges.Also Read: Pfizer share rises nearly 7% after firm says COVID-19 vaccine 95% effective


BusinessToday.In
November 19, 2020
India Stock Market Highlights Today: Infosys, HCL Tech, SBI, Airtel, HUL were among the top losers today, while Bajaj twins, Tata Steel, Titan, ONGC, M&M, NTPC were among the top gainers on Sensex pack 


BusinessToday.In
November 18, 2020
Pfizer and BioNTech informed that primary efficacy analysis of their coronavirus vaccine candidate showed that it was 95 per cent effective beginning 28 days after the first dose


BusinessToday.In
November 18, 2020
India Stock Market Highlights Today: Sensex closed 227 points higher at 44,180 and Nifty ended 64 points higher at 12,938. Shares of M&M , L&T and IndusInd  Bank were the top Sensex gainers rising up to 10.76%


BusinessToday.In
November 17, 2020
The early results provide strong signals that the coronavirus vaccine could prevent a majority of disease when large groups of people are vaccinated. However, the actual efficacy could be known only after the final results are out once the stage 3 trials end


BusinessToday.In
November 17, 2020
India Stock Market Highlights Today: Global equities were buoyed today as positive macroeconomic data flow and hopes of a COVID-19 vaccine boosted investor sentiment


BusinessToday.In
November 17, 2020
Catch top stories from the world of business and economy with BusinessToday.In's Biz EOD report


BusinessToday.In
November 16, 2020
Moderna stated that its COVID-19 vaccine candidate remains stable for 30 days at 2-degree Celsius to 8-degree Celsius, the temperature of a standard home or medical refrigerator


BusinessToday.In
November 16, 2020
BioNTech's CEO and Co-founder Ugur Sahin said, if everything continues to go well, the vaccine would begin to be delivered at the \"end of this year, beginning of next year.\"


PTI
November 15, 2020
Cronavirus cases in India: The number of active COVID-19 cases in the country stands at 4,79,216, which comprise 5.44 per cent of the total caseload


BusinessToday.In
November 15, 2020
As per Anthony Fauchi, the Pfizer's vaccine distribution process in the US will start in December. This, he said, will also help reduce the daily spike in coronavirus cases, which reached 1.9 lakh this week


Reuters
November 15, 2020
Under the agreement, the company will commit approximately $604 million and the US govt will commit about $454 million to support the Phase 3 clinical trial


BusinessToday.In
November 13, 2020
Pfizer and BioNTech recently announced that their vaccine candidate BNT162b2 has shown over 90 per cent efficacy in preventing coronavirus, as per data from Phase III clinical trials


BusinessToday.In
November 13, 2020
On nations hoarding vaccine stocks to meet their requirements first, Dmitriev said it is not about vaccine nationalism and that India is an important partner


Associated Press
November 13, 2020
Trump, fresh off his reelection loss to President-elect Joe Biden, remains angry that an announcement about progress in developing a vaccine for the disease came after Election Day


PAGES 3 OF 35  12345